Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
2 studies found for:    18032779 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Recruiting Relationship of Haptoglobin Phenotype to Vascular Function and Response to Vitamin E Supplementation in Patients With Diabetes Mellitus Type 2: The EVAS Trial
Condition: Diabetes Mellitus
Interventions: Dietary Supplement: Vitamin E;   Other: Placebo
2 Terminated Prevention of Cardiovascular Complications in Diabetic Patients With Vitamin E Treatment
Conditions: Diabetes;   Myocardial Infarction;   Cardiovascular Disease
Intervention: Drug: Natural source Vitamin E 400IU/day

Indicates status has not been verified in more than two years